Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Alembic Pharmaceuticals

Alembic Pharmaceuticals

BSE: 533573|NSE: APLLTD|ISIN: INE901L01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 19, 16:00
562.60
-2.25 (-0.4%)
VOLUME 809
LIVE
NSE
Nov 19, 15:56
565.00
-0.15 (-0.03%)
VOLUME 32,635
News on Alembic Pharmaceuticals
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Hold Alembic Pharma; target of Rs 560: ICICI Direct

3.59 pm | 24 Oct 2018 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated October 23, 2018....

Alembic Pharma Q2 profit up 64% to Rs 200 cr

3.01 pm | 22 Oct 2018 |  Source: PTI

The company had posted a net profit of Rs 121.56 crore in the year-ago period, Alembic Pharma said in a filing to BSE....

Alembic Pharma gains nearly 2% on successfully clearing first USFDA inspection

1.35 pm | 22 Oct 2018 |  Source: Moneycontrol.com

The scheduled inspection was carried out between October 15 and 19, 2018....

Stocks in the news: HDFC Bank, Persistent, Bhageria, SBI Life, Lupin, Reliance Power, SH Kelkar

7.44 am | 22 Oct 2018 |  Source: Moneycontrol.com

SBI Life| Asian Paints | Lupin | Reliance Power | HDFC Bank | Container Corporation and Tata Steel are stocks, which are in news today....

Alembic Pharma Q2 PAT may dip 9.3% YoY to Rs. 110 cr: HDFC Securities

6.17 pm | 17 Oct 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 18.8 percent Y-o-Y (up 8.7 percent Q-o-Q) to Rs. 940 crore, according to HDFC Securities....

Alembic Pharma gets USFDA nod for diabetes drug

1.21 pm | 16 Oct 2018 |  Source: PTI

The company has received tentative approval from the US Food and Drug Administration (USFDA) for its Alogliptin tablets in the strengths of 6.25 mg, 1...

Alembic Pharma gains 3% on USFDA approval for anti-diabetic drug

11.48 am | 16 Oct 2018 |  Source: Moneycontrol.com

Alogliptin drug has an estimated market size of $65.6 million for twelve months ending December 2017 according to IQVIA....

Alembic Pharma Q2 PAT may dip 4.5% YoY to Rs. 116.1 cr: ICICI Direct

3.34 pm | 12 Oct 2018 |  Source: Moneycontrol.com

Net Sales are expected to increase by 20.7 percent Y-o-Y (up 10.4 percent Q-o-Q) to Rs. 952.3 crore, according to ICICI Direct....

Hold Alembic Pharma; target of Rs 525: ICICI Direct

4.11 pm | 31 Jul 2018 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 525 in its research report dated July 30, 2018....

Alembic Pharma consolidated Jun-2018 sales at Rs 862.53 crore

5.13 pm | 27 Jul 2018

Alembic Pharmaceuticals has reported a consolidated total income from operations of Rs 862.53 crore and a net profit of Rs 90.47 crore for the quarter...

Alembic Pharma Q1 profit jumps 36% to Rs 90.5 cr on growth across territories

2.08 pm | 27 Jul 2018 |  Source: Moneycontrol.com

Alembic Pharma's profit increased to Rs 90.5 crore compared to Rs 66.7 crore in same period last fiscal....

Hold Alembic Pharma; target of Rs 460: ICICI Direct

5.52 pm | 24 May 2018 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 460 in its research report dated May 17, 2018....

1 2
Quick Links for Alembic Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.